The Food and Drug Administration has flagged Guillain-Barre syndrome, a rare neurological condition, as a potential risk for Pfizer’s respiratory syncytial virus vaccine.
Updating results
Vaccination is still the top method of preventing serious illness, experts involved in the research say.
A federal mandate for health care workers to get vaccinated against COVID-19 has been in place nationally for a year. An Associated Press analysis has identified about 750 nursing homes and 110 hospitals nationwide that have been cited for violations.
Time is running out for free-to-consumer COVID-19 vaccines, at-home test kits and some treatments.
Buckingham Palace confirmed in a statement that Camilla, Queen Consort had tested positive for COVID-19 on Monday.
A growing online conspiracy theory is using the tagline “died suddenly” to baselessly claim that COVID-19 vaccines are killing people.
Bird flu outbreak could lead to new poultry vaccinations.
Not big on needles? There may be a future where you can drink your COVID-19 vaccine. Researchers are expanding their focus into other forms of…
The federal Covid vaccination program is scheduled to transition to the private market as early as the fall. How this affects your access and …
The U.S. is poised to make COVID-19 vaccinations more like a yearly flu shot, a major shift in strategy despite a long list of questions about how to best protect against a still rapidly mutating virus.
The Food and Drug Administration’s advisory panel is set to meet this week in regards to considering an annual schedule for coronavirus vaccin…
Researchers say that the two might be linked. Veuer’s Tony Spitz has the details.
President Joe Biden notches two years in office on Friday. That represents 730 days since his inauguration and a whole lot of other numbers as…
WEDNESDAY, Jan. 11, 2023 (HealthDay News) -- COVID-19 vaccine acceptance has increased, reaching 79.1 percent, but there is considerable variation in vaccine hesitancy between countries, according to a study published online Jan. 9 in Nature Medicine.
WEDNESDAY, Jan. 11, 2023 (HealthDay News) -- While COVID-19 vaccine acceptance rose around the world between 2021 and 2022, wide gaps remain, according to new research.
Our beautiful girl Claudia. She is a very independent cat that loves the occasional cuddles.
Scientists have developed a vaccine that could prevent and even cure brain cancer.
Mpox, formerly known as monkeypox, is no longer the exploding health crisis that it appeared to be six months ago. So who deserves the credit for controlling the U.S. outbreak?
MONDAY, Jan. 9, 2023 (HealthDay News) -- Individuals who develop myocarditis following a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine have no difference in vaccine-induced immune responses compared with asymptomatic vaccinated controls, although free spike antigen is detected in those who develop vaccine-induced myocarditis, according to a study published online Jan. 4 in Circulation.
THURSDAY, Jan. 5, 2023 (HealthDay News) -- Racial/ethnic disparities are seen in COVID-19 vaccination coverage among children and adolescents, according to research published in the Jan. 6 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Some long-forgotten infectious diseases could surge in 2023.
TUESDAY, Jan. 3, 2023 (HealthDay News) -- For the 2021 to 2022 influenza season, influenza vaccines were 36 percent effective against influenza A(H3N2)-related illnesses, according to a study published online Dec. 12 in Clinical Infectious Diseases.
TUESDAY, Jan. 3, 2023 (HealthDay News) -- Patients with a history of multisystem inflammatory syndrome in children (MIS-C) do not have an increased risk for serious adverse events after COVID-19 vaccination, according to a study published online Jan. 3 in JAMA Network Open.
The long-awaited cancer vaccine revolution is getting a little closer to reality. New data from Moderna Inc. and Merck and Co. suggest that after decades of failures, researchers are finally figuring out the right way to design a vaccine that can teach immune cells how to recognize and combat tumors.
TUESDAY, Jan. 3, 2023 (HealthDay News) -- It's safe for kids to take the COVID-19 vaccine after they’ve suffered a rare complication from a prior COVID infection, a U.S. National Institutes of Health-supported study has concluded.